Comparative Efficacy and Safety of Ipragliflozin vs. Sitagliptin for Type 2 Diabetes: A Systematic Review and Meta-Analysis
Artículo
Acceso abierto
Artículo
DOAJ
OBJECTIVE: Type 2 diabetes mellitus (T2D) is a chronic metabolic disorder requiring effective management. Ipragliflozin (SGLT-2 inhibitor) and sitagliptin (DPP-4 inhibitor) are commonly used treatments with distinct mech...
LCC LCC:MedicineIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access